Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × FED × Melanoma × Clear all

Phase

Status

Sponsor Class

INDUSTRY 350 OTHER 279 NIH 55 OTHER_GOV 5 UNKNOWN 3 NETWORK 2 INDIV 1 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 4 Lung Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Motor Activity 2 Thoracic Neoplasms 1 Stroke 1 Prostatic Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms by Site 1 Neoplasms 1 Myasthenia Gravis 1 Melanoma 1 Lymphoproliferative Disorders 1 Lung Diseases 1 Liver Neoplasms 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia 1 Hematologic Neoplasms 1 Glioma 1 Glioblastoma 1 Esophageal Neoplasms 1 Diabetes Mellitus 1 Coronary Disease 1 Condylomata Acuminata 1 Colorectal Neoplasms 1 Carcinoma, Bronchogenic 1 Breast Neoplasms, Male 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00029900 2015-03-25

ADI-PEG in Patients With Metastatic Melanoma

FDA Office of Orphan Products Development

Phase 1 Completed

Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡